A Series of Patients with Kaposi Sarcoma (Mediterranean/Classical Type): Case Presentations and Short Update on Pathogenesis and Treatment
DOI:
https://doi.org/10.3889/oamjms.2018.354Keywords:
Kaposi, Pseudo-Kaposi, Stewart Treves syndrome, Radiation therapy, Treatment choice, Morbus MaliAbstract
BACKGROUND: Kaposi’s sarcoma was first described in 1872 by Moritz Kaposi. To date, it is considered a malignant disease is originating from the endothelial cells of the lymphatic vessels believed to be infected with HHV-8. The current classification defines four major epidemiological forms of Kaposi’s sarcoma: classical, endemic, AIDS-associated, and iatrogenic.
CASE REPORT: A 90-year-old male is presented with multiple plaques- and tumour-shaped brown-violet formations located on an erythematous-livid base in the area of both feet and both shanks. Two samples were taken from the lesions on the skin of the shanks, with histopathological examination and the subsequent immunohistochemistry showing Kaposi’s sarcoma.
CONCLUSIONS: Kaposi sarcoma is a disease that causes difficulties both in diagnostic and therapeutic respect. The only sure way to determine the correct diagnosis is immunohistochemical staining with the anti-HHV8 antibody. Despite the wide range of systematic and local treatment options, there is still no unified algorithm and a unified strategy for the treatment of Kaposi’s sarcoma.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Ojala P, Schulz T. Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation. Semin Cancer Biol. 2014; 26:69-77. https://doi.org/10.1016/j.semcancer.2014.01.008 PMid:24486643
Beral V. Epidemiology of Kaposi's sarcoma. Cancer Surv. 1991; 10:5-22. PMid:1821323
O'Connell K. Kaposi's sarcoma: histopathological study of 159 cases from Malawi. J Clin Path. 1977; 30:687-695. https://doi.org/10.1136/jcp.30.8.687 PMid:599182
Pantanowitz L, Otis C, Dezube B. Immunohistochemistry in Kaposi's sarcoma. Clin Exp Dermatol. 2010; 35(1):68-72. https://doi.org/10.1111/j.1365-2230.2009.03707.x PMid:19874352
Cattelan A, Trevenzoli M, Aversa S. Recent advances in the treatment of AIDS-related Kaposi's sarcoma. Am J Clin Dermatol. 2002; 3(7):451-62. https://doi.org/10.2165/00128071-200203070-00002 PMid:12180893
Shiels R. A history of Kaposi's sarcoma. J R Soc Med. 1986; 79(9):532–534. https://doi.org/10.1177/014107688607900910 PMid:3534266 PMCid:PMC1290459
Karamanou M, Antoniou C, Stratigos A, Saridaki Z, Androutsos G. The eminent dermatologist Moriz Kaposi (1837-1902) and the first description of idiopathic multiple pigmented sarcoma of the skin. J BUON. 2013; 18(4):1101-5. PMid:24344048
Sternbach G, Varon J. Moritz Kaposi: idiopathic pigmented sarcoma of the skin. J Emerg Med. 1995; 13(5):671-4. https://doi.org/10.1016/0736-4679(95)00077-N
Fatahzadeh M. Kaposi sarcoma: review and medical management update. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012; 113(1):2-16. https://doi.org/10.1016/j.tripleo.2011.05.011 PMid:22677687
Radu O, Pantanowitz L. Kaposi sarcoma. Arch Pathol Lab Med. 2013; 137(2):289-94. https://doi.org/10.5858/arpa.2012-0101-RS PMid:23368874
O'Donnell P, Pantanowitz L, Grayson W. Unique histologic variants of cutaneous Kaposi sarcoma. Am J Dermatopathol. 2010; 32(3):244-50. https://doi.org/10.1097/DAD.0b013e3181b7f6a7
Gutierrez KD, Morris VA, Wu D, Barcy S, Lagunoff M. Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. J Virol. 2013; 87(12):6758-68. https://doi.org/10.1128/JVI.03241-12 PMid:23552426 PMCid:PMC3676105
Berman M, Nalesnik M, Kapadia S, Rinaldo C, Jensen F. Primary lymphadenopathic Kaposi's sarcoma in an immunocompetent 23-year-old man. Am J Clin Pathol. 1986; 86(3):366-9. https://doi.org/10.1093/ajcp/86.3.366 PMid:3752000
Hirschel B, Wyss M, Thélin O, Cox J. Lymphadenopathic form of Kaposi's sarcoma (KS) in an African child. No evidence for acquired immunodeficiency syndrome (AIDS). Helv Paediatr Acta. 1985; 40(6):481-4. PMid:3007397
David O, Sani I, Azuhq P, Samaila M, Shehu M, Abdullah A. Lymphadenopathic Kaposi's sarcoma in an immunocompetent adult. J Coll Physicians Surg Pak. 2012; 22(6):403-5. PMid:22630105
Castelli E, Wollina U. Histopathologic features of progression in Mediterranean and immunodeficiency-related Kaposi sarcoma. Am J Dermatopathol. 2000; 22(1):89-91. https://doi.org/10.1097/00000372-200002000-00019 PMid:10698226
Wahman A, Melnick S, Rhame F, Potter J. The epidemiology of classic, African, and immunosuppressed Kaposi's sarcoma. Epidemiol Rev. 1991; 13:178-99. https://doi.org/10.1093/oxfordjournals.epirev.a036068 PMid:1765111
Mehta S, Garg A, Gupta L, Mittal A, Khare A, Kuldeep C. Kaposi's sarcoma as a presenting manifestation of HIV. Indian J Sex Transm Dis AIDS. 2011; 32(2):108–110. https://doi.org/10.4103/0253-7184.85415 PMid:22021973 PMCid:PMC3195171
Cahoon E, Linet M, Clarke C, Pawlish K, Engels E, Pfeiffer R. Risk of Kaposi sarcoma after solid organ transplantation in the United States. Int J Cancer. 2018. https://doi.org/10.1002/ijc.31735 PMid:29987894
Blumenfeld W, Egbert B, Sagebiel R. Differential diagnosis of Kaposi's sarcoma. Arch Pathol Lab Med. 1985; 109(2):123-7. PMid:2983633
Pantanowitz L, Dezube B. Kaposi sarcoma in unusual locations. BMC Cancer. 2008; 8:190. https://doi.org/10.1186/1471-2407-8-190 PMid:18605999 PMCid:PMC2464778
Rosado F, Itani D, Coffin C, Cates J. Utility of immunohistochemical staining with FLI1, D2-40, CD31, and CD34 in the diagnosis of acquired immunodeficiency syndrome-related and non-acquired immunodeficiency syndrome-related Kaposi sarcoma. Arch Pathol Lab Med. 2012; 136(3):301-4. https://doi.org/10.5858/arpa.2011-0213-OA PMid:22372906
Audard V, Lok C, Trabattoni M, Wechsler J, Brousse N, Fraitag S. [Misleading Kaposi's sarcoma: usefulness of anti HHV-8 immunostaining]. Ann Pathol. 2003; 23(4):345-8. PMid:14597899
Salameire D, Templier I, Charles J, Pinel N, Morand P, Leccia M, Lantuejoul S. An "anaplastic" Kaposi's sarcoma mimicking a Stewart-Treves syndrome. A case report and a review of literature. Am J Dermatopathol. 2008; 30(3):265-8. https://doi.org/10.1097/DAD.0b013e318169fd5f PMid:18496429
Tchernev G, Yungareva I, Mangarov H, Stavrov K, Lozev I, Temelkova I, Chernin S, Pidakev I, Tronnier M. Pretibial Located Stewart-Treves Syndrome: Uncommon Presentation in a Bulgarian Patient!. Open Access Maced J Med Sci. 2018; 6(4):663–665. https://doi.org/10.3889/oamjms.2018.191 PMid:29731936 PMCid:PMC5927499
Tchernev G, Patterson J, Ananiev J, Tronnier M. Unilateral presentation of pseudo-Kaposi's acroangiodermatitis--a diagnostic and therapeutic challenge. Vojnosanit Pregl. 2012; 69(4):370-3. https://doi.org/10.2298/VSP1204370T PMid:22624432
Wollina U. Angiosarcoma: an immunogenic tumour. Br J Dermatol. 2018; 179, pp239–259.
Harris BHL, Walsh JL, Neciunaite R et al. Ring a ring oʼroses, a patient with Kaposiʼs? Pazopanib, pazopanib, it might go away. Mediterranean(classic) Kaposi sarcoma responds to the tyrosine kinase inhibitor pazopanib after multiple lines of standard therapy. Clin Exp Dermatol. 2018; 43:234-236. https://doi.org/10.1111/ced.13302 PMid:29282751
Sullivan R, Pantanowitz L. New drug targets in Kaposi sarcoma. Expert Opin Ther Targets. 2010; 14(12):1355-66. https://doi.org/10.1517/14728222.2010.532336 PMid:21043836
Geara F, Le Bourgeois P, Piedbois P, Pavlovitch M, Mazeron J. Radiotherapy in the management of cutaneous epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys. 1991; 21(6):1517-22. https://doi.org/10.1016/0360-3016(91)90327-Z
RamÃrez K, Zavala J, Morán D, Hernández D, Jiménez A. Classic Kaposi's sarcoma - complete response to radiation therapy: a case report. J Med Case Rep. 2016; 10:322. https://doi.org/10.1186/s13256-016-1101-6 PMid:27832802 PMCid:PMC5105307
Donato V, Guarnaccia R, Dognini J, de Pascalis G, Caruso C, Bellagamba R, Morrone A. Radiation therapy in the treatment of HIV-related Kaposi's sarcoma. Anticancer Res. 2013; 33(5):2153-7. PMid:23645769
Piedbois P, Frikha H, Martin L, Levy E, Haddad E, Le Bourgeois J. Radiotherapy in the management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys. 1994; 30(5):1207-11. https://doi.org/10.1016/0360-3016(94)90330-1
Chang J, Kim I. Role of radiotherapy in local control of non-AIDS associated Kaposi's sarcoma patients in Korea: a single institution experience. Radiat Oncol J. 2012; 30(4):153–157. https://doi.org/10.3857/roj.2012.30.4.153 PMid:23346533 PMCid:PMC3546282
Aboulafia D. Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy. Mayo Clin Proc. 1998; 73(5):439-43. https://doi.org/10.1016/S0025-6196(11)63726-9
Nagy S, Gyulai R, Kemeny L, Szenohradszky P, Dobozy A. Iatrogenic Kaposi's sarcoma: HHV8 positivity persists but the tumors regress almost completely without immunosuppressive therapy. Transplantation. 2000; 69(10):2230-1. https://doi.org/10.1097/00007890-200005270-00053 PMid:10852635
Vincenzi B, D'Onofrio L, Frezza A, Grasso R, Fausti V, Santini D, Tos A, Tonini G. Classic Kaposi Sarcoma: to treat or not to treat? BMC Res Notes. 2015; 8:138. https://doi.org/10.1186/s13104-015-1076-1 PMid:25889316 PMCid:PMC4395989
WHO. Guidelines on the Treatment of Skin and Oral HIV-Associated Conditions in Children and Adults. Geneva: World Health Organization, 2014.
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
